Cargando…

What Is the Place of Intermediate Care Unit in Patients with COVID-19? A Single Center Experience

INTRODUCTION: COVID-19 pandemic has led to an increased rate of intensive care unit (ICU) stays. Intermediate care units (IMCUs) are a useful resource for the management of patients with severe COVID-19 that do not require ICU admission. In this research, we aimed to determine survival outcomes and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bülbül, Hale, Derviş Hakim, Gözde, Ceylan, Cengiz, Aysin, Murat, Köse, Şükran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139809/
https://www.ncbi.nlm.nih.gov/pubmed/37122395
http://dx.doi.org/10.1155/2023/8545431
_version_ 1785033026374205440
author Bülbül, Hale
Derviş Hakim, Gözde
Ceylan, Cengiz
Aysin, Murat
Köse, Şükran
author_facet Bülbül, Hale
Derviş Hakim, Gözde
Ceylan, Cengiz
Aysin, Murat
Köse, Şükran
author_sort Bülbül, Hale
collection PubMed
description INTRODUCTION: COVID-19 pandemic has led to an increased rate of intensive care unit (ICU) stays. Intermediate care units (IMCUs) are a useful resource for the management of patients with severe COVID-19 that do not require ICU admission. In this research, we aimed to determine survival outcomes and parameters predicting mortality in patients who have been admitted to IMCU. MATERIALS AND METHODS: Patients who were admitted to IMCU between April 2019 and January 2021 were analyzed retrospectively. Sociodemographics, clinical characteristics, and blood parameters on admission were compared between the patients who died in IMCU and the others. Blood parameters at discharge were compared between survived and deceased individuals. Survival analysis was performed via Kaplan–Meier analysis. Blood parameters predicting mortality were determined by univariate and multivariate Cox regression analysis. RESULTS: A total of 140 patients were included within the scope of this study. The median age was 72.5 years, and 77 (55%) of them were male and 63 (45%) of them were female. A total of 37 (26.4%) patients deceased in IMCU, and 40 patients (28.5%) were transferred to ICU. Higher platelet count (HR 3.454; 95% CI 1.383–8.625; p=0.008), procalcitonin levels (HR 3.083; 95% CI 1.158–8.206; p=0.024), and lower oxygen saturation (HR 4.121; 95% CI 2.018–8.414; p < 0.001) were associated with an increased risk of mortality in IMCU. At discharge from IMCU, higher procalcitonin levels (HR 2.809; 95% CI 1.216–6.487; p=0.016), lower platelet count (HR 2.269; 95% CI 1.012–5.085; p=0.047), and noninvasive mechanic ventilation requirement (HR 2.363; 95% CI 1.201–4.651; p=0.013) were associated with an increased risk of mortality. Median OS was found as 41 days. The overall survival rate was found 40% while the IMCU survival rate was 73.6%. CONCLUSIONS: IMCU seems to have a positive effect on survival in patients with severe COVID-19 infection. Close monitoring of these parameters and early intervention may improve survival rates and outcomes.
format Online
Article
Text
id pubmed-10139809
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-101398092023-04-28 What Is the Place of Intermediate Care Unit in Patients with COVID-19? A Single Center Experience Bülbül, Hale Derviş Hakim, Gözde Ceylan, Cengiz Aysin, Murat Köse, Şükran Int J Clin Pract Research Article INTRODUCTION: COVID-19 pandemic has led to an increased rate of intensive care unit (ICU) stays. Intermediate care units (IMCUs) are a useful resource for the management of patients with severe COVID-19 that do not require ICU admission. In this research, we aimed to determine survival outcomes and parameters predicting mortality in patients who have been admitted to IMCU. MATERIALS AND METHODS: Patients who were admitted to IMCU between April 2019 and January 2021 were analyzed retrospectively. Sociodemographics, clinical characteristics, and blood parameters on admission were compared between the patients who died in IMCU and the others. Blood parameters at discharge were compared between survived and deceased individuals. Survival analysis was performed via Kaplan–Meier analysis. Blood parameters predicting mortality were determined by univariate and multivariate Cox regression analysis. RESULTS: A total of 140 patients were included within the scope of this study. The median age was 72.5 years, and 77 (55%) of them were male and 63 (45%) of them were female. A total of 37 (26.4%) patients deceased in IMCU, and 40 patients (28.5%) were transferred to ICU. Higher platelet count (HR 3.454; 95% CI 1.383–8.625; p=0.008), procalcitonin levels (HR 3.083; 95% CI 1.158–8.206; p=0.024), and lower oxygen saturation (HR 4.121; 95% CI 2.018–8.414; p < 0.001) were associated with an increased risk of mortality in IMCU. At discharge from IMCU, higher procalcitonin levels (HR 2.809; 95% CI 1.216–6.487; p=0.016), lower platelet count (HR 2.269; 95% CI 1.012–5.085; p=0.047), and noninvasive mechanic ventilation requirement (HR 2.363; 95% CI 1.201–4.651; p=0.013) were associated with an increased risk of mortality. Median OS was found as 41 days. The overall survival rate was found 40% while the IMCU survival rate was 73.6%. CONCLUSIONS: IMCU seems to have a positive effect on survival in patients with severe COVID-19 infection. Close monitoring of these parameters and early intervention may improve survival rates and outcomes. Hindawi 2023-04-20 /pmc/articles/PMC10139809/ /pubmed/37122395 http://dx.doi.org/10.1155/2023/8545431 Text en Copyright © 2023 Hale Bülbül et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bülbül, Hale
Derviş Hakim, Gözde
Ceylan, Cengiz
Aysin, Murat
Köse, Şükran
What Is the Place of Intermediate Care Unit in Patients with COVID-19? A Single Center Experience
title What Is the Place of Intermediate Care Unit in Patients with COVID-19? A Single Center Experience
title_full What Is the Place of Intermediate Care Unit in Patients with COVID-19? A Single Center Experience
title_fullStr What Is the Place of Intermediate Care Unit in Patients with COVID-19? A Single Center Experience
title_full_unstemmed What Is the Place of Intermediate Care Unit in Patients with COVID-19? A Single Center Experience
title_short What Is the Place of Intermediate Care Unit in Patients with COVID-19? A Single Center Experience
title_sort what is the place of intermediate care unit in patients with covid-19? a single center experience
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139809/
https://www.ncbi.nlm.nih.gov/pubmed/37122395
http://dx.doi.org/10.1155/2023/8545431
work_keys_str_mv AT bulbulhale whatistheplaceofintermediatecareunitinpatientswithcovid19asinglecenterexperience
AT dervishakimgozde whatistheplaceofintermediatecareunitinpatientswithcovid19asinglecenterexperience
AT ceylancengiz whatistheplaceofintermediatecareunitinpatientswithcovid19asinglecenterexperience
AT aysinmurat whatistheplaceofintermediatecareunitinpatientswithcovid19asinglecenterexperience
AT kosesukran whatistheplaceofintermediatecareunitinpatientswithcovid19asinglecenterexperience